MyChart is not for medical emergencies. If you have a medical emergency, call 911.
If you need help with MyChart, call us at 1-844-442-4278
The goal of breast cancer screening is to find cancer at the earliest possible stage, before it causes symptoms or pain and when it is easier to treat. UChicago Medicine offers mammography at several locations, including our main location in Chicago and at several locations in Chicago's Southland.
At UChicago Medicine, our board-certified radiologists provide the full range of image interpretation and image-guided procedures to uncover signs of disease, including:
2D digital mammography, breast ultrasound and breast MRI (magnetic resonance imaging)
Much of our radiologists' work is integrated with colleagues in our Breast Center — medical oncologists, radiation oncologists, surgeons and pathologists. This collaboration includes performing procedures to better identify the precise location of a tumor for patients who need surgery; using MRI to monitor patients undergoing chemotherapy before surgery (called neoadjuvant chemotherapy); and performing screening for patients who have a strong family history of breast cancer or a genetic predisposition to cancer.
UChicago Medicine's main campus location in Hyde Park, UChicago Medicine at Ingalls - Harvey and UChicago Medicine at Ingalls - Tinley Park are designated as Breast Imaging Centers of Excellence by the American College of Radiology. A center of excellence designation is awarded to breast imaging centers that have demonstrated excellence and achieved full accreditation in mammography, breast ultrasound, breast ultrasound-guided biopsy and stereotactic breast biopsy.
Approximately 40 percent of women have dense breast tissue which can obscure small tumors, making them difficult to detect with routine mammography. Whole breast ultrasound can be used along with mammography to examine dense breast tissue. In accordance with Illinois law, our highly experienced radiologists report breast density to both patients and referring providers. This information is useful in determining whether or not additional breast screening should be considered.
Between 5 and 10 percent of breast cancers are thought to be hereditary and are caused by mutations in a person's gene. UChicago Medicine offers a comprehensive breast cancer risk and prevention program for patients who may have inherited a gene mutation associated with breast cancer (e.g. BRCA1 and BRCA2). Our oncologists work in tandem with board-certified genetic counselors to help patients understand the risks and benefits associated with genetic testing, guide them through appropriate screening and prevention options and provide more information for their family and their care.
The American Cancer Society recommends the following breast cancer screening guidelines for most women:
Discuss with your health care provider:
Understanding the biological makeup of breast cancer is an important first step to beating this disease. UChicago Medicine's breast cancer program includes board-certified pathologists who focus their practice on benign and malignant breast diseases. Dedicated pathology assistants ensure specimens are prepared effectively for fast and accurate pathology results. These results play a key role in informing treatment planning.
Beyond the initial pathology results, our pathologists provide crucial insight and expertise in the multidisciplinary treatment of breast cancer patients.
A longstanding debate has stymied the medical community about when and how often women should be screened for breast cancer. The WISDOM study will assess whether personalized screening is as safe, effective and accepted compared to annual screening.Watch Video Watch Video With Transcript